Molecule intelOpportunity: ModerateEssentialCrowded market

Meropenem

203 brands · 81 companies · product forms

ATC: J01DH02 3 DRAP alerts

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
90
203
brands
81
companies
Rs 2,240.36
median price
248
price points
1,077.47x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 82.61
MedianRs 2,240.36
Most expensiveRs 89,010.08
Spread1,077.47×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 1077.47x across 248 trusted points (Rs 82.61-89010.08). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Meropenem — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2022-06-02
Drug Product Recall: Meronem Injection (Batch # 4B20E273) by M/s Pfizer Pakistan Limited,
Drug Product Recall: M/S. Pfizer Pakistan Limited, Karachi issues nation wide voluntary re
Voluntary Recall Alert: Drug Product; Meronem 1g Injection (Batch #4A20B27 and Batch # 4A2

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

81 canonical companies and 203 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 1077.47x across 248 trusted points (Rs 82.61-89010.08). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

3 DRAP alert(s), latest 2022-06-02 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.